Stock Market & Financial Investment News

News Breaks March 13, 2013 05:31 EDT NVS Novartis announces data from Phase III studies of Gilenya at AAN New data will be presented at the 65th annual meeting of the American Academy of Neurology, or AAN, that show continued innovation within the Novartis Multiple Sclerosis, or MS, portfolio. Growing clinical trial and real-world experience with Gilenya, the first once-daily oral therapy approved to treat people with relapsing MS,will be highlighted. Updates on studies of Gilenya in people with primary-progressive MS and the investigational agent BAF312 in people with secondary-progressive MS will also be communicated. Data from three large Phase III studies will highlight the efficacy of Gilenya in reducing the rate of brain volume loss, the best characterized MRI predictor of long-term disability. There will also be a presentation on the INFORMS study, which is evaluating Gilenya in patients with primary-progressive MS. This form of MS affects about 10% of people with MS and follows a steady course of worsening neurologic function for which there are no approved disease modifying treatments. News For NVS From The Last 14 Days Check below for free stories on NVS the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. May 21, 2013 07:44 EDT NVS Sachs Associates to host a forum Subscribe for More Information 07:24 EDT NVS Global Health Care to host a conference Subscribe for More Information May 20, 2013 07:29 EDT NVS Deutsche Bank to host a conference dbAccess Asia Conference 2013 is being held in Singapore on May 20-22. May 17, 2013 16:20 EDT NVS Novartis drug Afinitor extended time without disease progression in women Subscribe for More Information May 16, 2013 08:11 EDT NVS Novartis says no intention of pursuing Actavis, Bloomberg reports Subscribe for More Information May 15, 2013 19:37 EDT NVS Novartis weighing Actavis bid, WSJ reports Subscribe for More Information 18:17 EDT NVS Novartis weighs possible bid for Actavis, DJ reports Subscribe for More Information May 10, 2013 05:42 EDT NVS Novartis drug Ilaris approved by FDA Subscribe for More Information Sign up for a free trial to see the rest of the stories you've been missing.